Peer Review reports
From: Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
| Original Submission | ||
|---|---|---|
| 2 Apr 2021 | Submitted | Original manuscript |
| 23 May 2021 | Reviewed | Reviewer Report |
| 30 May 2021 | Reviewed | Reviewer Report |
| 8 Jun 2021 | Author responded | Author comments - Biyun Wang |
| Resubmission - Version 2 | ||
| 8 Jun 2021 | Submitted | Manuscript version 2 |
| 9 Jun 2021 | Author responded | Author comments - Biyun Wang |
| Resubmission - Version 3 | ||
| 9 Jun 2021 | Submitted | Manuscript version 3 |
| 15 Jun 2021 | Reviewed | Reviewer Report |
| 17 Jun 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 27 Oct 2021 | Editorially accepted | |
| 2 Nov 2021 | Article published | 10.1186/s12885-021-08921-2 |
You can find further information about peer review here.